Vyome Holdings, Inc HIND
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2016-10-06
Vyome Holdings, Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 68.4% | 2.4% | 63.9% | 60.5% | 61.4% | 55.4% | 10.1% | 40.4% | 51.3% | 17.2% |
| Operating margin | -3269.4% | -12.6% | -177.3% | -412.4% | -425.6% | -110.2% | -708.0% | -406.2% | -346.9% | -574.9% |
| Net margin | -3209.7% | -18.1% | -131.2% | -411.2% | -464.3% | -191.4% | -721.6% | -410.7% | -350.7% | -603.2% |
| FCF margin | — | — | — | — | — | -77.2% | -702.8% | -337.5% | -319.4% | -581.2% |
| Return on assets | -157.9% | -104.8% | -106.8% | -414.8% | -120.2% | -58.4% | -116.1% | -123.0% | -65.5% | -26.0% |
| Return on equity | -272.8% | 33.0% | -170.9% | -1262.3% | -142.4% | -149.3% | -98.2% | -285.2% | -99.0% | -31.8% |
| Debt / equity | — | — | — | — | — | 0.92× | 0.00× | 0.76× | 0.28× | 0.15× |
| Current ratio | 1.99 | 0.05 | 2.73 | 1.32 | 3.98 | 0.77 | 4.59 | 1.66 | 5.17 | 17.00 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.